Is Zura Bio Stock a Good Investment?
Zura Bio Investment Advice | ZURA |
- Examine Zura Bio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Zura Bio's leadership team and their track record. Good management can help Zura Bio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact Zura Bio's business and its evolving consumer preferences.
- Compare Zura Bio's performance and market position to its competitors. Analyze how Zura Bio is positioned in terms of product offerings, innovation, and market share.
- Check if Zura Bio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Zura Bio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Zura Bio Limited stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Zura Bio Limited is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Mild | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Zura Bio Stock
Researching Zura Bio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 29.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.65. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zura Bio Limited recorded a loss per share of 0.75. The entity had not issued any dividends in recent years.
To determine if Zura Bio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Zura Bio's research are outlined below:
| Zura Bio Limited is way too risky over 90 days horizon | |
| Zura Bio Limited may become a speculative penny stock | |
| Zura Bio Limited appears to be risky and price may revert if volatility continues | |
| Zura Bio Limited has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (52.4 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zura Bio generates negative cash flow from operations | |
| About 71.0% of the company outstanding shares are owned by institutional investors |
Zura Bio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Zura Bio Limited. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Zura Bio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Zura Bio's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 90.34 M.Basic technical analysis of Zura Stock
As of the 5th of August, Zura Bio maintains the Downside Deviation of 3.94, market risk adjusted performance of 0.5225, and Mean Deviation of 4.35. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zura Bio Limited, as well as the relationship between them.Zura Bio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zura Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zura Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zura Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zura Bio's Outstanding Corporate Bonds
Zura Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zura Bio Limited uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zura bonds can be classified according to their maturity, which is the date when Zura Bio Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand Zura Bio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Zura Bio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0746 | |||
| Market Risk Adjusted Performance | 0.5225 | |||
| Mean Deviation | 4.35 | |||
| Semi Deviation | 3.45 | |||
| Downside Deviation | 3.94 | |||
| Coefficient Of Variation | 1221.74 | |||
| Standard Deviation | 8.03 | |||
| Variance | 64.4 | |||
| Information Ratio | 0.0665 | |||
| Jensen Alpha | 0.5039 | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | 0.1355 | |||
| Treynor Ratio | 0.5125 | |||
| Maximum Drawdown | 61.89 | |||
| Value At Risk | (7.50) | |||
| Potential Upside | 9.57 | |||
| Downside Variance | 15.5 | |||
| Semi Variance | 11.89 | |||
| Expected Short fall | (7.39) | |||
| Skewness | 4.44 | |||
| Kurtosis | 27.39 |
| Risk Adjusted Performance | 0.0746 | |||
| Market Risk Adjusted Performance | 0.5225 | |||
| Mean Deviation | 4.35 | |||
| Semi Deviation | 3.45 | |||
| Downside Deviation | 3.94 | |||
| Coefficient Of Variation | 1221.74 | |||
| Standard Deviation | 8.03 | |||
| Variance | 64.4 | |||
| Information Ratio | 0.0665 | |||
| Jensen Alpha | 0.5039 | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | 0.1355 | |||
| Treynor Ratio | 0.5125 | |||
| Maximum Drawdown | 61.89 | |||
| Value At Risk | (7.50) | |||
| Potential Upside | 9.57 | |||
| Downside Variance | 15.5 | |||
| Semi Variance | 11.89 | |||
| Expected Short fall | (7.39) | |||
| Skewness | 4.44 | |||
| Kurtosis | 27.39 |
Consider Zura Bio's intraday indicators
Zura Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zura Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Zura Bio time-series forecasting models is one of many Zura Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zura Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Zura Stock media impact
There is far too much social signal, news, headlines, and media speculation about Zura Bio that are available to investors today. This information is accessible both publicly - through Zura Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Zura-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Zura Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Zura Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Zura Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Zura Bio alpha.
Zura Bio Corporate Management
| Gary Whale | Chief Officer | Profile | |
| David Brady | Head Development | Profile | |
| Kiran MBBS | Chief Development | Profile | |
| Eric Hyllengren | Chief Officer | Profile | |
| Kimberly Davis | Chief Secretary | Profile | |
| Theresa Lowry | Chief Officer | Profile |
Already Invested in Zura Bio Limited?
The danger of trading Zura Bio Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Zura Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Zura Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Zura Bio Limited is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zura Bio Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Zura Bio's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.